Rishi Gupta is Director at Verona Pharma plc (VRNA). They have made 5 open-market trades across 4 companies since 2015, most recently 2025-08-08.
CIK 0001537370
2 open-market purchases totalling $7.6M since 2015, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ELVN | SELL | 2024-05-16 | 2024-05-20 | $22.14 | $22.9M | -6.0% | -12.3% | -2.0% |
| TSBX | BUY | 2023-07-20 | 2023-07-24 | $12.00 | $5.0M | +6.8% | -19.5% | -76.1% |
| VRNA | SELL | 2023-05-11 | 2023-05-15 | $20.82 | $11.7M | +5.0% | +4.8% | -10.3% |
| VRNA | SELL | 2022-12-22 | 2022-12-27 | $22.31 | $200.7M | +0.8% | -4.5% | -14.6% |
| DMTX | BUY | 2015-10-27 | 2015-10-29 | $13.00 | $2.6M | -32.1% | -7.1% | -35.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.